Renalytix plc
RENXF- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001811115
No open-market purchases or sales by Renalytix plc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesRNLXY
13F holders, Q1 2022
Institutional positions in Renalytix plc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 2
- −1 vs. Q4 2021
- Shares held
- 175.2K
- −47.7K (−21.4%) vs. Q4 2021
- Total value
- $622.0K
- −$1.25M (−66.8%) vs. Q4 2021
- New holders
- 0
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RENXF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 2 | $622.0K |
| Q4 2021 | 3 | $1.87M |
| Q3 2021 | 3 | $2.18M |
| Q2 2021 | 3 | $3.62M |
| Q1 2021 | 2 | $4.43M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Renalytix plc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tiaa, FSB | 161,019 | $572.0K | 0.00% | 00.0% | Unchanged |
| Public Employees Retirement System of Ohio | 14,187 | $50.0K | 0.00% | 00.0% | Unchanged |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −47,725−100.0% | Sold out |